Back to Search
DR. SARAH GEAN GORE M.D.
M.D.
Diagnostic Radiology Physician
NPI: 1770803751IndividualAccepts Medicare
Specialties, Licenses & Credentials
Diagnostic Radiology PhysicianPrimary
Radiology — Diagnostic Radiology
Code: 2085R0202X
ME127295(FL)
Education
UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE
Class of 2010
Research & Publications (20)
Trends in health sciences library and information science research: an analysis of research publications in the Bulletin of the Medical Library Association and Journal of the Medical Library Association from 1991 to 2007.
PMID 19626146·J Med Libr Assoc·2009
8-other
Neuronal differentiation in basal cell carcinoma: possible relationship to Hedgehog pathway activation?
PMID 19479712·J Pathol·2009
8-other
MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation.
PMID 19652201·Blood·2009
3-trial
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review.
PMID 19167676·Biol Blood Marrow Transplant·2009
6-review
Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies.
PMID 19546476·Blood·2009
3-trial
Design, synthesis and pharmacological screening of novel nitric oxide donors containing 1,5-diarylpyrazolin-3-one as nontoxic NSAIDs.
PMID 19647903·Eur J Med Chem·2009
7-preclinical
Design, synthesis and pharmacological screening of novel antihypertensive agents using hybrid approach.
PMID 19036593·Bioorg Med Chem·2009
7-preclinical
Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia: a preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib (R115777, Zarnestra) combined with etoposide.
PMID 19109557·Blood·2009
3-trial
Novel 4-(morpholin-4-yl)-N'-(arylidene)benzohydrazides: synthesis, antimycobacterial activity and QSAR investigations.
PMID 19464085·Eur J Med Chem·2009
8-other
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.
PMID 19230772·Lancet Oncol·2009
3-trial
The impact of cumulative childhood adversity on young adult mental health: measures, models, and interpretations.
PMID 18177989·Soc Sci Med·2008
8-other
DNA methyltransferase and histone deacetylase inhibitors in the treatment of myelodysplastic syndromes.
PMID 18179966·Semin Hematol·2008
6-review
p21(WAF1/CIP1) induction by 5-azacytosine nucleosides requires DNA damage.
PMID 18223691·Oncogene·2008
8-other
Derepression in the desert: the third workshop on clinical translation of epigenetics in cancer therapeutics.
PMID 18593891·Cancer Res·2008
8-other
Phase II trial of tipifarnib as maintenance therapy in first complete remission in adults with acute myelogenous leukemia and poor-risk features.
PMID 18483374·Clin Cancer Res·2008
3-trial
Future directions in myelodysplastic syndrome: newer agents and the role of combination approaches.
PMID 18813208·Cancer Control·2008
6-review
Chest wall reconstruction using a turbocharged chimaeric anterolateral thigh flap.
PMID 17392046·J Plast Reconstr Aesthet Surg·2008
5-case
Comparative modelling by restraint-based conformational sampling.
PMID 18237407·BMC Struct Biol·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via OHIO DRIVE MEDICAL ASSOCIATES PC · 2 locations total
- Address
- 6 OHIO DR
NEW HYDE PARK, NY 11042 - Phone
- (516) 222-2022
Quick Facts
- NPI
- 1770803751
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 16
- Publications
- 20
Are you this provider?
Claim Your Profile